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Methylglyoxal is a faulty metabolite. It is a ubiquitous by-product of glucose and amino acid
metabolism that spontaneously reacts with proximal amino groups in proteins and nucleic
acids, leading to impairment of their function. The glyoxalase pathway evolved early in
phylogeny to bring about rapid catabolism of methylglyoxal, and an understanding of the role
of methylglyoxal and the glyoxalases in many diseases is beginning to emerge. Metabolic
processing of methylglyoxal is very rapid in vivo and thus notoriously difﬁcult to detect and
quantify. Here we show that 13C nuclei in labeled methylglyoxal can be hyperpolarized using
dynamic nuclear polarization, providing 13C nuclear magnetic resonance signal enhancements
in the solution state close to 5,000-fold. We demonstrate the applications of this probe of
metabolism for kinetic characterization of the glyoxalase system in isolated cells as well as
mouse brain, liver and lymphoma in vivo.
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Methylglyoxal (MeGx) is formed both inside cells
1–3 and
in blood plasma4–6, primarily as a by-product of gly-
colysis7,8 and amino acid metabolism9, with a total
daily production estimated at 0.2–1.2 g in the adult human8,10. As
a ketoaldehyde, MeGx is highly reactive and spontaneously
modiﬁes side chain amino groups in proteins and nucleic acids,
leading to impairment of their function and degradation11. Initial
catabolism of MeGx occurs via the glyoxalase pathway12,13, which
consists of glyoxalase I (Glo1, enzyme commission number
4.4.1.5, lactoylglutathione lyase) and glyoxalase II (Glo2, enzyme
commission number 3.1.2.6, hydroxyacylglutathione hydrolase),
which in red blood cells (RBCs) have a maximum ﬂux capacity
~100 times that of glycolysis14,15. The pathway requires reduced
glutathione (GSH) as a co-substrate and converts MeGx into D-
lactate (D-Lac) (as opposed to the L-lactate produced by glycolysis
in higher organisms16), which is then further metabolized in
peroxisomes17. Understanding the fate of MeGx in biology and its
role in disease development is beginning to emerge18. Additional
functions of MeGx and the glyoxalase pathway in cell physiology
remain largely unresolved.
The kinetics of MeGx catabolism has been studied previously
in dilute lysates of RBCs using 1H nuclear magnetic resonance
(NMR) spectroscopy15. However, due to poor intrinsic sensitivity
of NMR and the need to accumulate each NMR spectrum for ~4
min, the glyoxalase reactions appeared to be too fast to study in
intact cells and tissues (going to completion in <1 min). We
demonstrate here, using rapid dissolution dynamic nuclear
polarization (RD-DNP)19, that it is possible to monitor the
glyoxalase pathway non-invasively in whole cells and tissues, on
the sub-minute timescale. Using hyperpolarization, we achieve
~5,000-fold enhancements in NMR sensitivity, which allows
detection and quantiﬁcation of the glyoxalase reactions in RBCs
and mouse tissues in vivo.
Results
Synthesis of 13C-labeled methylglyoxal. Two isotopomers of 13C-
labeled MeGx, [2-13C]MeGx and [1,3-13C]MeGx, were synthesized
from [2-13C]acetone and [1,3-13C]acetone, respectively. The syn-
thetic procedure was adapted from a method for radiolabeling
MeGx20 and described in Methods. Since the 13C nucleus at the C2
position in MeGx does not have any attached protons (Fig. 1), it has
a much larger NMR longitudinal relaxation time T1 and hence
longer nuclear polarization lifetime than the C1 or C3 carbons.
Consequently, we observed better spectral quality in RD-DNP time
courses obtained with hyperpolarized [2-13C]MeGx and therefore
focused on this isotopomer. (Results obtained with [1,3-13C]MeGx
are shown in Supplementary Figure 1.) The purity of the synthe-
sized [2-13C]MeGx was conﬁrmed by one-dimensional (1D) 1H
(Supplementary Figure 2), 1D 13C (Supplementary Figure 3) and
two-dimensional (2D) 1H-13C HMBC (Supplementary Figure 4)
NMR spectra. MeGx is spontaneously hydrated (Fig. 1) and 1H and
13C NMR spectra conﬁrmed that it exists as three interchanging (on
the sub-minute timescale) forms in aqueous solution, viz., free keto-
aldehyde (MG), the monohydrate (MGMH), and the bishydrate
(MGBH), which at 37 oC were in the ratio 1:71:28 (keto-aldehyde:
MGMH:MGBH).
Detection of methylglyoxal catabolism in whole cells. A solu-
tion of hyperpolarized [2-13C]MeGx was injected into an RBC
suspension that was thermally pre-equilibrated at 37 °C inside the
NMR spectrometer bore, and a series of 1D 13C NMR spectra (1 s
per spectrum) was acquired using a small ﬂip angle (~4°) exci-
tation pulse. The emergence of SLG and D-Lac, the respective
products of Glo1 and Glo2, demonstrated rapid catabolism of
MeGx by the glyoxalase pathway in RBCs (Fig. 2a).
Hyperpolarization led to high spectral signal-to-noise ratios for all
the MeGx species (~200:1 for MGMH), despite the [2-13C]MeGx
concentration in the sample of only 1.3mM. In comparison, a
signal-to-noise ratio of ~12:1 was achieved for MGMH in 13C-NMR
spectra of non-hyperpolarized ~40mM [2-13C]MeGx in D2O,
recorded from 64 transients in 4min (Supplementary Figure 3).
Thus, the DNP signal enhancement was ~5000.
The MGMH resonance declined rapidly due to glyoxalase-
mediated ﬂux and longitudinal relaxation, whereas the MGBH
resonance declined more slowly despite a similar T1 (see below
for estimates of these parameter values), primarily because
MGMH is the intermediate that feeds rapidly onto the free
ketoaldehyde (MG) and the rest of the pathway, while exchange
between the two hydrated species is relatively slower. The smaller
resonances from the ketoaldehyde and hemithioacetal (HTA)
persisted in the spectra (Fig. 2b), consistent with continuing
regeneration of these minor forms during the ﬂow of 13C label
from MGMH/MGBH via MG/HTA to SLG and D-Lac (Fig. 1).
SLG was prominent initially (at ~2 s) and declined thereafter,
consistent with a very fast build-up catalyzed by Glo1, followed
by removal in the reaction catalyzed by Glo2, with concurrent
loss of signal due to T1 relaxation.
The emergence of D-Lac occurred more slowly than for SLG, as
expected for a metabolite that is further downstream. A similar
pattern of labeling was evident in RBC lysates (Supplementary
Figure 5) and in suspensions of murine lymphoma EL4 cells
(Supplementary Figure 6).
Quantiﬁcation of glyoxalase kinetics in whole RBCs. Figure 2c
shows the temporal evolution of 13C-labeled MGMH, MGBH,
SLG and D-Lac, obtained upon injection of four different amounts
of [2-13C]MeGx (ﬁnal concentrations of 1.05, 2.1, 4.7 and 9.4
mM). The time at which the maximum D-Lac peak intensity
occurred varied only slightly with changes in the concentration of
[2-13C]MeGx. The extent of reaction, indicated by the relative
maximum amplitude of the D-Lac signal, was highest for the
lowest starting concentration of MeGx. Also, at higher substrate
concentrations the glyoxalase system became partially saturated.
The MGMH signal showed an apparent single-exponential decay,
as expected for the main substrate species, while MGBH showed
the appearance of a bi-exponential decay, consistent with 13C
label ﬂowing through MGMH prior to yielding the other two
products. SLG was formed so fast that its maximum amplitude
occurred shortly after MeGx addition; while D-Lac showed the
rise-and-fall proﬁle expected for a product at the end of a reaction
sequence, as has previously been observed21–24.
The rate constants describing 13C label ﬂux were estimated by
iterative ﬁtting of the following (continuous) differential
equations, which were integrated numerically, to the signal
intensities in Fig. 2c:
d½MGBH
dt
¼  1
TMGBH1
MGBH½ k1 MGBH½  þ k1 MGMH½ 
d½MGMH
dt
¼  1
TMGMH1
MGMH½   kGlo1 MGMH½ 
k1 MGMH½  þ k1 MGBH½ 
d SLG½ 
dt
¼  1
TSLG1
SLG½   kGlo2 SLG½  þ kGlo1 MGMH½ 
d½Lac
dt
¼  1
TLac1
Lac½  þ kGlo2½SLG;
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where T1MGBH, T1MGMH, T1SLG, T1Lac are the longitudinal
relaxation times of the indicated species; k1, k−1, kGlo1, kGlo2, are
the kinetic rate constants shown in Fig. 1 and [MGBH*],
[MGMH*], [SLG*], and [Lac*] are the concentrations of the
corresponding hyperpolarized species. The solid lines in Fig. 2c
show the ﬁtting results.
Initially, we considered RD-DNP time courses from samples in
which cell suspensions had low cytocrits (3–9.5%). Due to the low
overall glyoxalase activity, the 13C-NMR signal intensities in such
spectral series were dominated by just two species, MGBH and
MGMH (e.g., Supplementary Figure 6b), which allowed inde-
pendent estimation of the hydration-exchange constants
k1 and k−1 as well as the two T1 values: k1= 0.039 ± 0.009 s−1;
k−1= 0.015 ± 0.005 s−1; T1MGBH= 19.3 ± 5.3 s and T1MGMH=
16.0 ± 1.9 s. The obtained best-ﬁt parameters for each trial are
given in Supplementary Tables 1-8. The estimated values for k1
and k−1 compare favorably with those reported previously for
dilute hemolysates, 0.051 ± 0.004 s−1 and 0.021 ± 0.004 s−1,
estimated using a magnetization transfer method15.
The estimated values of T1MGBH, T1MGMH, k1 and k−1 were
then ﬁxed in subsequent regression trials in which the other
intermediate metabolites had much higher concentrations due to
higher cytocrit values (39–40%). Fitting of the kinetic model to
the data shown in Fig. 2c gave a T1SLG of 0.9 ± 0.3 s, which was
consistent with the presence of a proton directly bonded to 13C in
the lactoyl moiety, which provides an efﬁcient dipole-dipole
relaxation pathway. The T1 of [2-13C]D-lactate was also small
compared with those of the methylglyoxal species, at 5.3 ± 1.2 s.
Estimates of the glyoxalase (kGlo1 and kGlo2) rate constants were
obtained by ﬁtting the data shown in Fig. 2c, plus two additional
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Fig. 1 Glyoxalase pathway of methylglyoxal catabolism. Ketoaldehyde form of methylglyoxal (MG) is spontaneously thiolated by reduced glutathione
(GSH) (reaction 3), which is followed by the two reactions catalyzed by glyoxalase I (4) and glyoxalase II (5), producing S-D-lactoylglutathione (SLG) and
D-lactic acid (D-Lac), respectively. There are also two spontaneous hydration reactions of the keto-aldehyde form, (1) and (2)
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data sets with the initial total MeGx concentration of 17.7 and
35.4 mM (Supplementary Figure 7). Best-ﬁt parameters obtained
by ﬁtting the Bloch-McConnell model to these data are
summarized in Supplementary Table 9. Figure 3a shows the
dependence of the apparent rate constant for the reaction
catalyzed by Glo1 (kGlo1) on the total initial concentration of
MeGx. Regressing the Michaelis–Menten equation onto the data
of Fig. 3a yielded an apparent VGlo1max;app of 1.2 ± 0.4 mM s
−1 and
Km,app of 2.9 ± 1.3 mM. Since HTA is the true substrate for Glo1,
the enzyme kinetic parameters were converted according to
formulae derived in Methods: VGlo1max ¼ V
Glo1;app
max ½GSH
½ K1þ1ð ÞK2þ1K3, which gave
(assuming [GSH]= 2.2 mM in the RBCs15,25) VGlo1max of 0.22 ±
0.07 mM s−1, or 33.4 ± 10.6 mmol min−1 (L RBC)−1. Similarly,
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Fig. 2 RD-DNP time courses acquired following injection of hyperpolarized [2-13C]methylglyoxal into a suspension of RBCs. a 13C NMR spectra obtained
upon injection of 1 mL of hyperpolarized [2-13C]MeGx into 3 mL of RBCs (hematocrit, Ht, of 52%) in phosphate-buffered saline giving a ﬁnal concentration
of 1.3 mM. Spectra were acquired every 1 s. *Denotes position of spectral artifact that was edited out. b Expansion of the 200-215 ppm region of the bottom
spectrum in shown in a. c 13C NMR peak intensities of the four main species in spectra acquired following injection of different concentrations of [2-13C]
MeGx into suspensions of RBCs (ﬁnal Ht values 39–40%). Data points were scaled so that the initial sums of the peak amplitudes of MGMH and MGBH
were equal to the nominal concentrations of injected MeGx. The solid lines are nonlinear least squares ﬁts of numerical solutions of the array of differential
equations. Abbreviations: D-Lac, [2-13C]D-lactate; HTA, hemithioacetal of [2-13C]MeGx; MG, the ketoaldehyde form of [2-13C]MeGx; MGBH, the
bishydrate of [2-13C]MeGx; MGMH, the monohydrate of [2-13C]MeGx; SLG, [2-13C]S-D-lactoylglutathione; DMSO, natural abundance 13CD3 in the
dimethylsulfoxide-d6 used to make up the hyperpolarization solution
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the apparent Km for MGMH was converted to that for HTA via
the expression derived in Methods:
KGlo1m ¼ K
Glo1;app
m
KGlo1m ½ K1þ1ð ÞK2þ1K3
½GSH 1þ
½GSH
KGSH
i
 , which gave KGlo1m = 0.42 ± 0.19
mM. The latter value is very close to the previously reported Km
for Glo1, 0.46 mM15, while VGlo1max is smaller by a factor of two
than in dilute hemolysates15. This discrepancy can be partly
explained by a large accumulation of non-hyperpolarized, and
hence invisible, methylglyoxal thus leading to an underestimate of
the true carbon ﬂux.
The enzyme kinetic plot for Glo2 (Fig. 3b) displayed less
convincing Michaelis–Menten dependence of the apparent rate
constant on the (total MeGx) substrate concentration. The scatter
and standard errors of the experimental data were large, leading to
unreliable parameter estimates, viz., VGlo2;appmax = 1.2 ± 2.2mM s−1
and KGlo2;appm = 2.2 ± 7.3 mM.
Detection of glyoxalase activity in vivo. Following experiments
on suspensions of murine lymphoma EL4 cells, where we
observed reaction time courses similar to those in RBCs (Sup-
plementary Figure 6), we studied [2-13C]MeGx metabolism in
EL4 tumors implanted subcutaneously in mice (n= 3), as well as
mouse liver and brain. A solution of hyperpolarized [2-13C]MeGx
was injected into the tail vein of mice that were positioned in a
horizontal bore 7 T magnet; and NMR signals were detected using
a 2 cm diameter surface coil placed over the tissue of interest. As
in the cell suspension studies, rapid appearance of the glyoxalase
products was detected in all studied tissues. Spectra that had
maximum intensities for SLG and D-Lac are shown in Fig. 4 (all
spectra acquired for up to 20 s are shown in Supplementary
Figures 8-10).
The 13C NMR spectra from EL4 tumors (Supplementary
Figure 8) were similar to those from brain (Supplementary Figure 9)
and liver (Supplementary Figure 10), but a notable feature was the
slower rise of the 13C signals, with MGBH only appearing after 4 s
in contrast to 2 s in the other two tissues. D-Lac appeared before
other spectral features at 3 s and was still present after 18 s. SLGmax
was observed at 9 s, later than in both the liver and the brain.
Overall, the EL4 tumors appeared to metabolize [2-13C]MeGx at a
rate comparable to liver and brain, but after a further 2 s delay, that
is consistent with the longer vascular path from the heart to the
dermis on the ﬂank of the animal, and then into the tumor. The
rates of D-Lac production in the three tissues were similar to those
observed in RBC suspensions.
Discussion
Production of D-Lac in the glyoxalase pathway involves a
sequence of four reactions (dehydration of hydrated MeGx →
thiolation of the ketoaldehyde by GSH → elimination/lyation via
Glo1 → hydrolysis via Glo2), which is amongst the longest
sequences of reactions observed using a hyperpolarized 13C-
labeled substrate. Another example of a system involving four
sequential reactions is detection of 13C label from [2-13C]pyr-
uvate in citrate and glutamate, having passed via acetyl-CoA and
isocitrate, respectively;26 and hyperpolarized [U-13C]D-glucose
produces detectable amounts of dihydroxyacetone phosphate and
L-lactate via the 11 reactions of glycolysis27. Because the meta-
bolism of MeGx lies outside the mainstream energy-transducing
pathways, it is like another renegade or faulty metabolite, 2-
hydroxyglutarate, excessive accumulation of which is implicated
in cancer28. These types of metabolites are appealing as probes of
altered gene expression, capable of distinguishing one tissue from
another, and neoplastic cells from their normal counterparts.
Glyoxalase I is known to be overexpressed in tumors29 and has
been proposed as a prognosis factor for cancer progression30.
13C-labeled D-lactate could also be hyperpolarized and used to
track its fate in various tissues using similar methodology (or with
local catheterization and perfusion of an organ or tumor). [2-13C]
MeGx could also be used as a precursor of endogenously pro-
duced [2-13C]D-lactate for this purpose.
Overall, we demonstrated that kinetic probing of the glyoxalase
pathway is possible by using the RD-DNP method, with potential
clinical imaging applications. We developed a reliable method for
the synthesis of [2-13C]MeGx and demonstrated hyperpolarization
of this material using RD-DNP methodology, with signal
enhancements of ~5000-fold. We showed that hyperpolarized [2-
13C]MeGx can be used to probe glyoxalase activity in RBCs, murine
lymphoma EL4 cells in vitro, as well as mouse brain, liver and EL4
tumors in vivo. The glyoxalase kinetic parameters obtained in RBCs
showed good agreement with those obtained previously using other
NMR and light-spectroscopy methods, although the estimated
maximal velocity of Glo1 was 2-fold lower than expected, a fact that
requires further investigation. Finally, [2-13C]MeGx, combined with
RD-DNP and 13C NMR, holds promise as an in vivo probe of
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Fig. 3 Apparent rate constants of the two glyoxalase reactions in RBC
suspensions as functions of total concentration of injected methylglyoxal.
The data were derived from ﬁtting the time courses of 13C NMR peak
intensities shown in Fig. 2c, plus two data sets obtained with [MeGx]=
17.5 and 34.5mM (Supplementary Figure 7). a Black discs represent the
best-ﬁt values of kGLO1, given in Supplementary Table 9 (mean ± SE). The
solid orange line is a nonlinear least squares regression of the
Michaelis–Menten expression for glyoxalase 1, giving VGlo1max;app of 1.2 ± 0.4
mM s−1 and a Km,app of 2.9 ± 1.3 mM. b Black discs represent the best-ﬁt
values of kGLO2, given in Supplementary Table 9 (mean ± SE). The solid
orange line is an attempt at nonlinear least squares regression of the
Michaelis–Menten expression for glyoxalase 2
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differential glyoxalase expression, and hence the basis of dis-
criminating between normal and pathological tissues.
Methods
Chemicals and solutions. Analytical reagents were from Sigma-Aldrich (St Louis,
MO, USA) unless stated otherwise. [2-13C]Acetone and [1,3-13C]acetone were
from Cambridge Isotope Laboratories (Andover, MA, USA). Osmolalities of cell
media were adjusted to 290 ± 5 mOsm kg−1 using a vapor pressure osmometer
(Model 5520, Wescor Instruments, Logan, UT, USA).
Synthesis of 13C-labeled methylglyoxal. [2-13C]MeGx was synthesized by
adapting methods used previously for radiolabeling20,31. Namely, 2.5 g of selenium
dioxide (Fluka, Germany) was dissolved in 10 g of MilliQ water (Merck Millipore,
Burlington, MA, USA). Then, 1 g of [2-13C]acetone was added and the mixture was
brought to 60 °C in an evacuated vial. Shortly after, a red precipitate began to form,
and the reaction mixture was kept at 60˚C for 8 h. After cooling to room tem-
perature, the yellow-orange liquid was distilled under reduced pressure. A 1H NMR
spectrum of the distillate boiling at 56–60 °C revealed a mixture that consisted
mostly of water and methylglyoxal, with small amounts of acetate and formate.
Finally, the distillate was freeze-dried overnight, which removed most of the water,
acetate and formate, leaving a pale-yellow viscous oil-like liquid. Samples were
stored at −20 °C until use. After dissolving the ﬁnal product in D2O, the 1H and
13C NMR spectra (Supplementary Figures 2-4) showed MeGx of high purity, with
only small quantities of oligomeric species, which were decomposed into mono-
meric methylglyoxal upon incubation in H2O at room temperature32. The ﬁnal-
product yield was ~10%. The procedure for synthesis of [1,3-13C]MeGx was
identical, with [1,3-13C]acetone used as a starting material.
Preparation of cell cultures. Blood was obtained from consenting healthy donors,
under Human Ethics Committee clearance. Heparin (15 U mL−1) was used as an
anti-coagulant and blood was centrifuged at 3000 × g for 5 min at 4 °C. The plasma
and buffy coat were removed by vacuum-pump aspiration. RBC pellets were
washed three times in ﬁve volumes of phosphate-buffered saline (PBS) and prior to
the last wash cell suspensions were bubbled with oxygen for 10 min, converting
hemoglobin to diamagnetic oxyhemoglobin. Hematocrits were measured using a
capillary centrifuge (12000 × g; Hermle, Z252M, Wehingen, Germany). Samples
were stored at 4 °C for up to 24 h until used. In experiments with hemolysates, RBC
suspensions were subjected to two cycles of freezing in liquid nitrogen and thawing
at ~30 °C. Samples were typically used on the same day.
The murine lymphoma EL4 cells were cultured in Roswell Park Memorial
Institute (RPMI) medium using the protocol provided by the supplier (ATCC,
Manassas, VA, USA).
NMR spectroscopy. Non-hyperpolarized 1H and 13C NMR spectra were recorded
at 400.13 and 100.6 MHz, respectively, on a Bruker (Karlsruhe, Germany) Avance
III console with a 9.4 T vertical wide-bore magnet from Oxford Instruments
(Oxford, UK), equipped with a 10-mm Bruker TXI or a broadband (BBO) probe.
For the RD-DNP experiments with cell suspensions or lysates, a Bruker Avance
II 600MHz spectrometer (150.9 MHz for 13C) with a 14.1 T vertical magnet and
10-mm Bruker broadband probe were used to record the 13C NMR spectra. The
13C NMR RD-DNP spectra were acquired as reported recently;23 viz., each was
based on a single free induction decay (FID) of 32,768 complex data points
acquired with a repetition time of 1 s. FID acquisition time was 0.806 s; spectral
width was 269.35 ppm; the carrier frequency was set to 120 ppm; the duration of
the radio-frequency pulse was 1 μs, which corresponded to a nutation (ﬂip) angle of
4o. The data were processed with one degree of zero ﬁlling and multiplication with
an exponential line-broadening factor of 1 Hz before Fourier transformation. 13C
NMR chemical shifts of each of MGBH and MGMH were assigned as in33. For the
HTA and MG peaks, the assignment was done by adding extra GSH to a
hemolysate, which increased one of the two peaks that was then assigned to HTA.
NMR spectra were phased and baseline corrected in Bruker TopSpin 3.5, prior to
being imported into Mathematica34 for post-processing.
RD-DNP sample preparation. Approximately 30 mg (~0.4 mmol) of 13C-labeled
MeGx was dissolved in 140 μL of 50:50 DMSO-d6 and D2O containing 15 mM
trityl radical (tris(8-carboxy-2,2,6,6-tetra-(hydroxyethyl)-benzo-[1,2,4,5]-bis-(1,3)-
dithiole-4-yl)-methyl sodium salt (OX063, GE Healthcare, Amersham, Buck-
inghamshire, UK) and 0.7 mM of gadolinium chelate (Dotarem; Guerbet Labora-
tories Ltd, Solihull, West Midlands, UK). The mixture was hyperpolarized using a
3.35 T HyperSense (Oxford Instruments, Abingdon, UK), at a temperature of ~1.2
K using microwaves with a frequency of 94.115 GHz. The sample underwent rapid
dissolution in 6 mL of a solution containing 10 mM Na phosphate, 137 mM NaCl
and 2 mM KCl (pH 7.4 at 37 °C, at 10 bar and 180˚C) to give a ﬁnal MeGx
concentration of ~80 mM. Up to 2 mL of the hyperpolarized solution was injected
via a heat-exchange apparatus23 into samples of cells or lysates, which were pre-
equilibrated at 37 °C in a 10-mm NMR tube. The time from sample ejection to
injection into the lysate/cell-suspension was typically ~17 s. For the experiments on
anaesthetized mice, after a similar delay, 100 μL of the hyperpolarized solution was
injected via a caterer into the tail vein over ~10 s.
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Fig. 4 13C NMR spectra acquired from the liver, brain, and an EL4 tumor of
three different mice following injection of hyperpolarized [2-13C]MeGx.
Spectra were acquired every 1 s for 180 s. The spectra shown are those that
had the maximum resonance intensity for SLG and D-Lac. Full time-courses
are given in Supplementary Figures 8–10
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Tumor implantation. Animal experiments were conducted in compliance with
personal and project licenses issued under the UK Animals (Scientiﬁc Procedures)
Act, 1986. Experimental and handling protocols were approved by the Cancer
Research UK, Cambridge Institute Animal Welfare and Ethical Review Body.
As in35, tumors were initiated by subcutaneous injection of 5 × 106 viable EL4
murine lymphoma cells in 100 μL in the left ﬂank of C57BL/6 female mice (Charles
River Ltd., Harlow, Essex, UK) at 6-8 weeks of age and weighing ~20 g.
Experiments were conducted when the tumor volume was ~2 mL, typically 10 days
after implantation. The animals were fed ad libitum on standard mouse chow. They
were anaesthetized with inhalation of 1–2% isoﬂurane (IsoFlo, Abbott Laboratories
Ltd., Maidenhead, Berkshire, UK) in air/O2 (75/25%, 2 L min−1). Body
temperature was maintained with warm air blown though the magnet bore and was
recorded with a rectal thermometer. Breathing rate (~80 cycles min−1) and
temperature were recorded with a purpose-built device from Biotrig (Small Animal
Instruments, Stony Brook, New York, USA).
In vivo magnetic resonance spectroscopy. Experiments were conducted on a 7 T
horizontal-bore magnet (Agilent, Palo Alto, CA, USA) using an actively decoupled
double-tuned 13C-1H volume transmit coil (Rapid Biomedical, GmbH, Rimpar,
Germany; inside diameter 42 mm) and a 20-mm diameter 13C surface receiver coil
(Rapid Biomedical). Tumors were located with transverse 1H images acquired with
a spin-echo pulse sequence using a repetition time of 1.5 s, echo time of 10 ms, a
ﬁeld of view of 40 × 40 mm, a data matrix of 128 × 128 complex points, a slice
thickness of 2 mm, and 15 slices. Time courses were recorded as single transient
spectra from a 6-mm thick slice of the tumor (or brain or liver) acquired using a
slice-selective excitation pulse with an estimated ﬂip-angle of 10o. Using a repeti-
tion time of 1 s, 180 spectra were acquired in 3 min. The data were imported into a
MatLab (Mathworks, MA, USA) script and peaks were integrated. Further analyses
including graphical output were conducted in Mathematica34.
Quantitative analysis of time-course data. Initially, the glyoxalase pathway
reactions were modeled using the scheme shown in Supplementary Figure 11a,
which included ‘unlabeled’ (non-hyperpolarized) species. Each kinetic step was
accounted for by a ﬁrst-order rate constant, with kGlo1 and kGlo2 denoting
equivalent apparent ﬁrst-order rate constants that characterize the two enzymes.
Since the peak intensities of the ketoaldehyde form (MG) and HTA were low, and
attempts to include them in the ﬁtting process failed, we switched to a reduced
model (Supplementary Figure 11b). The extent of reaction was sufﬁciently small
that initial velocities could be estimated, including those of the glyoxalase reactions,
by nonlinear regression analysis using only the equations describing the time
dependence of the four major hyperpolarized species (Fig. 2c). Attempts to
incorporate the application of the small ﬂip-angle readout pulse, α, into the model
showed that the presence of the angle only affected the values of the apparent
longitudinal relaxation times, T1, in a predictable way (Supplementary Tables 1-7),
as described in36. Thus, for efﬁciency of the numerical procedures, the ﬁnal ﬁts
were performed by omitting application of α.
The Michaelis–Menten parameters were initially estimated in terms of the total
concentration of the injected methylglyoxal, [MeGx], (Fig. 3):
kGlo1 ¼
VGlo1;appmax
KGlo1;appm þ ½MeGx
kGlo2 ¼
VGlo2;appmax
KGlo2;appm þ ½MeGx
However, the true substrate of Glo1 is HTA, while the true substrate of Glo2 is
SLG. Moreover, GSH is a competitive inhibitor of Glo1, while HTA is a competitive
inhibitor of Glo215. Thus, the expressions for the rates of the two enzymes are of
the following Michaelis–Menten forms:15
υGlo1 ¼
VGlo1max ½HTA
KGlo1m 1þ ½GSHKGSHi
 
þ ½HTA
υGlo2 ¼
VGlo2max SLG½ 
KSLGm 1þ HTA½ KHTAi
 
þ SLG½ 
:
The true substrate concentrations can be expressed via the dissociation
equilibrium constants K1, K2 and K3, as follows from Fig. 1:
MGBH½ eq
MGMH½ eq
¼ k1
k1
¼ K1; hence MGBH½ eq¼ K1½MGMHeq
MGMH½ eq
MG½ eq
¼ k2
k2
¼ K2; hence MGMH½ eq¼ K2½MGeq
MG½ eq GSH½ eq
HTA½ eq
¼ k3
k3
¼ K3; hence MG½ eq¼
K3 HTA½ eq
GSH½ eq
½MeGx ¼ MGBH½ eqþ MGMH½ eqþ MG½ eq¼ K1 þ 1ð ÞK2½MGeq þ MG½ eq
½MeGx ¼ K1 þ 1ð ÞK2 þ 1½  MG½ eq¼
½ K1 þ 1ð ÞK2 þ 1K3 HTA½ eq
GSH½ eq
HTA½ eq¼
½MeGx GSH½ eq
½ K1 þ 1ð ÞK2 þ 1K3
;
where the subscript ‘eq’ denotes equilibrium. Assuming that a quasi-equilibrium
pertains, we omit the ‘eq’ subscript and obtain the following expressions for the
rate constants in terms of [MeGx]:
kGlo1 ¼ V
Glo1
max
KGlo1m 1þ½GSHKGSH
i
 
þ ½MeGx GSH½ ½ K1þ1ð ÞK2þ1K3
¼
¼
VGlo1max ½ K1þ1ð ÞK2þ1K3
½GSH
 
KGlo1m ½ K1þ1ð ÞK2þ1K3
½GSH 1þ
½GSH
KGSH
i
 
þ½MeGx
:
Thus, for estimating the Michaelis–Menten parameters for Glo1, the obtained
apparent value KGlo1;appm corresponds to
KGlo1m ½ K1þ1ð ÞK2þ1K3
½GSH 1þ ½GSHKGSHi
 
, while
VGlo1;appmax corresponds to
VGlo1max ½ K1þ1ð ÞK2þ1K3
½GSH
 
. These expressions were employed in
the calculations, using previously determined values of K1, K2, K3, KGSHi (0.412,
0.01925, 10.67 mM and 7.88 mM, respectively15) and [GSH]= ~2 mM in RBCs25.
General computations. Progress curves of NMR spectral intensity were ﬁtted by
straight lines or exponential curves using the Mathematica34 function Non-
linearModelFit. When comparing two different slopes for a statistically-signiﬁcant
difference the standard two-tailed t-test was used37.
Data Availability:
The data sets generated during and/or analyzed during the current study are
available from the corresponding author on reasonable request.
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